SKYLIGHT HEALTH GROUP INC (SLHG) Fundamental Analysis & Valuation

NASDAQ:SLHG • CA83086L2057

Current stock price

0.5847 USD
-0.01 (-1.75%)
At close:
0.588 USD
+0 (+0.56%)
After Hours:

This SLHG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SLHG Profitability Analysis

1.1 Basic Checks

  • In the past year SLHG has reported negative net income.
SLHG Yearly Net Income VS EBIT VS OCF VS FCFSLHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -5M -10M -15M -20M

1.2 Ratios

Industry RankSector Rank
ROA -42.34%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SLHG Yearly ROA, ROE, ROICSLHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 -200 -400 -600

1.3 Margins

Industry RankSector Rank
OM -61.09%
PM (TTM) -48.43%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLHG Yearly Profit, Operating, Gross MarginsSLHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -2K -4K -6K -8K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. SLHG Health Analysis

2.1 Basic Checks

  • SLHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SLHG has more shares outstanding
  • Compared to 1 year ago, SLHG has a worse debt to assets ratio.
SLHG Yearly Shares OutstandingSLHG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 10M 20M 30M
SLHG Yearly Total Debt VS Total AssetsSLHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 20M 40M 60M

2.2 Solvency

  • SLHG has an Altman-Z score of -1.43. This is a bad value and indicates that SLHG is not financially healthy and even has some risk of bankruptcy.
  • SLHG has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Altman-Z -1.43
ROIC/WACCN/A
WACC10.44%
SLHG Yearly LT Debt VS Equity VS FCFSLHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 10M -10M 20M 30M

2.3 Liquidity

  • SLHG has a Current Ratio of 1.21. This is a normal value and indicates that SLHG is financially healthy and should not expect problems in meeting its short term obligations.
  • SLHG has a Quick Ratio of 1.21. This is a normal value and indicates that SLHG is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.21
SLHG Yearly Current Assets VS Current LiabilitesSLHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. SLHG Growth Analysis

3.1 Past

  • SLHG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.00%.
  • Looking at the last year, SLHG shows a very strong growth in Revenue. The Revenue has grown by 383.90%.
  • The Revenue has been growing by 610.49% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
Revenue 1Y (TTM)383.9%
Revenue growth 3Y36.12%
Revenue growth 5Y610.49%
Sales Q2Q%133.78%

3.2 Future

  • SLHG is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.67% yearly.
  • Based on estimates for the next years, SLHG will show a very strong growth in Revenue. The Revenue will grow by 44.87% on average per year.
EPS Next Y-78.91%
EPS Next 2Y-13.11%
EPS Next 3Y-13.75%
EPS Next 5Y-10.67%
Revenue Next Year60.93%
Revenue Next 2Y51.58%
Revenue Next 3Y47.68%
Revenue Next 5Y44.87%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SLHG Yearly Revenue VS EstimatesSLHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
SLHG Yearly EPS VS EstimatesSLHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. SLHG Valuation Analysis

4.1 Price/Earnings Ratio

  • SLHG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year SLHG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLHG Price Earnings VS Forward Price EarningsSLHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -1.81
SLHG Per share dataSLHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • A cheap valuation may be justified as SLHG's earnings are expected to decrease with -13.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.11%
EPS Next 3Y-13.75%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SLHG Dividend Analysis

5.1 Amount

  • SLHG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

SLHG Fundamentals: All Metrics, Ratios and Statistics

SKYLIGHT HEALTH GROUP INC

NASDAQ:SLHG (8/24/2022, 8:00:02 PM)

After market: 0.588 +0 (+0.56%)

0.5847

-0.01 (-1.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-15
Earnings (Next)11-14
Inst Owners0.5%
Inst Owner Change-36.48%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.28M
Revenue(TTM)63.15M
Net Income(TTM)-30.58M
Analysts77.5
Price Target2.08 (255.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B 1.17
P/tB N/A
EV/EBITDA -1.81
EPS(TTM)-0.4
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.21
BVpS0.5
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -42.34%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -61.09%
PM (TTM) -48.43%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.21
Altman-Z -1.43
F-Score2
WACC10.44%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
EPS Next Y-78.91%
EPS Next 2Y-13.11%
EPS Next 3Y-13.75%
EPS Next 5Y-10.67%
Revenue 1Y (TTM)383.9%
Revenue growth 3Y36.12%
Revenue growth 5Y610.49%
Sales Q2Q%133.78%
Revenue Next Year60.93%
Revenue Next 2Y51.58%
Revenue Next 3Y47.68%
Revenue Next 5Y44.87%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

SKYLIGHT HEALTH GROUP INC / SLHG Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SKYLIGHT HEALTH GROUP INC (SLHG) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SLHG.


What is the valuation status for SLHG stock?

ChartMill assigns a valuation rating of 2 / 10 to SKYLIGHT HEALTH GROUP INC (SLHG). This can be considered as Overvalued.


Can you provide the profitability details for SKYLIGHT HEALTH GROUP INC?

SKYLIGHT HEALTH GROUP INC (SLHG) has a profitability rating of 0 / 10.